Table 3.
MIN-O line | MIN-O size at 5-weeks posttransplantation | Tumor latency (in weeks) | |||||
Ovx | |||||||
Control %FPF (n) | % FPF (n) | relative to control | p-value | Control TE50 | Ovx TE50 | p-value | |
4w-4 | 55.00 ± 10.00 (4) | 24.29 ± 9.76 (7) | 0.44 | 0.0008 | 10.1 | >10.1 | 0.113 |
4w-11 | 37.50 ± 17.08 (4) | 15.00 ± 18.17 (6) | 0.40 | 0.08 | 10.2 | 12.1 | 0.118 |
8w-B* | 67.50 ± 12.58 (4) | 22.86 ± 7.56 (7) | 0.34 | <0.0001 | 4.9 | 11.1 | 0.002 |
8w-D | 60.00 ± 0.00 (4) | 10.71 ± 4.50 (7) | 0.18 | <0.0001 | 8.15 | 12.1 | 0.017 |
* from Namba et al 2005